Founded

Address

DecImmune Therapeutics Inc
Cambridge, MA 00000
United States

Open map

Website
http://www.decimmune.com

Search trends
Patents
KANDO id: 130501

Corporate information

Registration country
United States

Company type

Developer of antibodies to reduce tissue damage and improve ventricular function associated with myocardial infarction

Funding rounds

Venture USD 2,250,000

USD 2,250,000 ( )


N/A


Profile Country
Astellas Venture Management LLC
United States

N/A


Profile Country
Healthcare Ventures LLC Venture capital firm focused on life sciences companies in pre-clinical and early clinical stage.
United States

N/A


Profile Country
Astellas Venture Capital LLC
United States


Investment activity status
Active investor

Current team

Past employees

Selected Products / Customers

Financials